These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 23428122)

  • 1. [Effect of gamma-aminobutyric acid treatment on plasma substance P and calcitonin gene-related peptide levels in children with asthma].
    Xu CW; Guo SC; Zheng ZW; Wang QY
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Feb; 15(2):102-4. PubMed ID: 23428122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased plasma substance P and CGRP levels, and high ACE activity in migraineurs during headache-free periods.
    Fusayasu E; Kowa H; Takeshima T; Nakaso K; Nakashima K
    Pain; 2007 Apr; 128(3):209-214. PubMed ID: 17123735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma concentration of selected neuropeptides in patients suffering from psoriasis.
    Reich A; Orda A; Wiśnicka B; Szepietowski JC
    Exp Dermatol; 2007 May; 16(5):421-8. PubMed ID: 17437485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum substance P and calcitonin gene-related peptide levels in Behçet's disease and their association with disease activity.
    Aki T; Karincaoglu Y; Seyhan M; Batcioglu K
    Clin Exp Dermatol; 2006 Jul; 31(4):583-7. PubMed ID: 16716167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of histamine H(2)-receptor antagonists on human plasma levels of calcitonin gene-related peptide, substance P and vasoactive intestinal peptide.
    Itoh H; Naito T; Takeyama M
    J Pharm Pharmacol; 2002 Nov; 54(11):1559-63. PubMed ID: 12495560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of electroacupuncture on cortical spreading depression and plasma CGRP and substance P contents in migraine rats].
    Shi H; Li JH; Ji CF; Shang HY; Qiu EC; Wang JJ; Jing XH
    Zhen Ci Yan Jiu; 2010 Feb; 35(1):17-21. PubMed ID: 20458901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma changes of calcitonin gene-related peptide and substance P in patients with dialysis headache.
    Alessandri M; Massanti L; Geppetti P; Bellucci G; Cipriani M; Fanciullacci M
    Cephalalgia; 2006 Nov; 26(11):1287-93. PubMed ID: 17059435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensory nerve terminal activity in severe hypertension as reflected by circulating calcitonin gene-related peptide (CGRP) and substance P.
    Edvinsson L; Erlinge D; Ekman R; Thulin T
    Blood Press; 1992 Dec; 1(4):223-9. PubMed ID: 1285370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of electroacupuncture on thermal pain threshold and expression of calcitonin-gene related peptide, substance P and γ-aminobutyric acid in the cervical dorsal root ganglion of rats with incisional neck pain.
    Qiao LN; Liu JL; Tan LH; Yang HL; Zhai X; Yang YS
    Acupunct Med; 2017 Aug; 35(4):276-283. PubMed ID: 28600329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heat coagulation of middle meningeal artery affects plasma CGRP and substance P levels in migraine rat triggered by nitroglycerin].
    Zhu X; Han Y; Xiong W; Wang H; Li J; Liu W; Fan Z
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 May; 25(10):460-2, 468. PubMed ID: 21809559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevation of plasma CGRP and SP levels in orthopedic patients with fracture neck of femur.
    Onuoha GN; Alpar EK
    Neuropeptides; 2000 Apr; 34(2):116-20. PubMed ID: 10985928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in plasma calcitonin gene-related peptide from the extracerebral circulation during nitroglycerin-induced cluster headache attack.
    Fanciullacci M; Alessandri M; Figini M; Geppetti P; Michelacci S
    Pain; 1995 Feb; 60(2):119-123. PubMed ID: 7540279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiles of blood biomarkers in alternating hemiplegia of childhood--increased MMP-9 and decreased substance P indicates its pathophysiology.
    Inui T; Saito Y; Sakuma H; Hatakeyama H; Goto Y; Arai H; Sasaki M
    Brain Dev; 2012 Mar; 34(3):196-200. PubMed ID: 21550738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dai-kenchu-to raises levels of calcitonin gene-related peptide and substance P in human plasma.
    Sato Y; Katagiri F; Inoue S; Itoh H; Takeyama M
    Biol Pharm Bull; 2004 Nov; 27(11):1875-7. PubMed ID: 15516741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Ninjin-to on levels of calcitonin gene-related peptide and substance P in human plasma.
    Sato Y; Katagiri F; Inoue S; Itoh H; Takeyama M
    Biol Pharm Bull; 2004 Dec; 27(12):2032-4. PubMed ID: 15577227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of single-file reciprocating systems on Substance P and Calcitonin gene-related peptide expression in human periodontal ligament.
    Caviedes-Bucheli J; Moreno JO; Carreño CP; Delgado R; Garcia DJ; Solano J; Diaz E; Munoz HR
    Int Endod J; 2013 May; 46(5):419-26. PubMed ID: 23062064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced levels of calcitonin gene-related peptide (CGRP) but not substance P during and after treatment of severe hypertension in man.
    Edvinsson L; Ekman R; Thulin T
    J Hum Hypertens; 1989 Aug; 3(4):267-70. PubMed ID: 2477545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of hange-shashin-to and rikkunshi-to on human plasma calcitonin gene-related peptide and substance P levels.
    Naito T; Itoh H; Takeyama M
    Biol Pharm Bull; 2003 Aug; 26(8):1104-7. PubMed ID: 12913259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cetraxate raises levels of calcitonin gene-related peptide and substance P in human plasma.
    Katagiri F; Sato Y; Itoh H; Takeyama M
    J Pharm Pharmacol; 2004 Apr; 56(4):557-61. PubMed ID: 15099451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of Suspending Moxibustion at "Dazhui" (GV 14) on Neurogenic Inflammation in Asthma Rats].
    Zhang W; Jiao L; Xiong J
    Zhen Ci Yan Jiu; 2015 Oct; 40(5):388-91. PubMed ID: 26669196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.